Lastly, the TGF-β signaling pathway has been extensively studied in GBM for its contributions to tumor invasiveness, immunosuppression, and maintenance of a tumorigenic microenvironment, making it a promising focus for therapeutic interventions [30]. The gene discussed is TGFB1; the disease is glioblastoma.